Recombinant human lysozyme (Changchun Qilong/Guoan Industrial/Shenzhen Jiuyixiang)

N/A

Report date: 2022/07/15 15:12:29

Base Information

Drug NameRecombinant human lysozyme (Changchun Qilong/Guoan Industrial/Shenzhen Jiuyixiang)
Drug Alias Name重组人溶解酶重组人溶解酵素
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionCell wall inhibitorsPeptidoglycan modulators
TargetsPeptidoglycan
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A